Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An announcement from Sharps Technology, Inc. ( (STSS) ) is now available.
On May 6, 2025, Sharps Technology announced the receipt of a $100,000 purchase order from a Hungarian vaccine provider for their SecureGard™ syringes, marking their transition to a revenue-producing company. This order, along with a $400,000 SoloGard™ order, contributes to a total of approximately $500,000 in orders for the quarter, indicating a significant milestone in their growth. The company also received an initial qualification order for the DisGard™ Sharps Recovery System, highlighting the expansion of their product lines and their strategic positioning in the healthcare industry.
More about Sharps Technology, Inc.
Sharps Technology is an innovative medical device and pharmaceutical packaging company that specializes in patented smart-safety syringe products. Their offerings focus on ultra-low waste capabilities with both passive and active safety features, and they support the prefillable syringe market with specialized copolymer technology. The company operates a manufacturing facility in Hungary.
Average Trading Volume: 708,114
Technical Sentiment Signal: Sell
Current Market Cap: $258.6K
Learn more about STSS stock on TipRanks’ Stock Analysis page.